May 7, 2015, NIAID Funding News
Read this full issue online at http://www.niaid.nih.gov/
Intellectual Property Considerations for Contracts: Data
If last month's article "Intellectual Property Considerations for Contracts: Inventions" piqued your interest, this one might do the same. Read the full article.
Opportunities and Resources
Work Toward a Preventive HIV Vaccine With HIVRAD
If you're ready to address important questions in AIDS prophylactic vaccine research, consider applying for funds through the HIV Vaccine Research and Design (HIVRAD) Program. Read the full article.
HCV Funding Opportunity: Take Two
If you saw the reissued NIH Guide announcement for Hepatitis C Cooperative Research Centers: Immunity to HCV Infection (U19) and thought you had an episode of déjà vu, you did. Read the full article.
Recent FDA Licensure Demonstrates NIAID’s Impact
You may know that last month the FDA approved filgrastim (trade name Neupogen®) to treat exposure to myelosuppressive doses of radiation by facilitating recovery of bone marrow cells.Read the full article.
In The News
NIH Business System Downtime May Affect You
If your award is scheduled to be issued in late May or early June, it will likely be delayed. Read the full article.
Reminder: New Biosketch Format Required Soon
Don't forget that the new biographical sketch format is required for grant applications with due dates on or after May 25, 2015. Read the full article.
Help NIH Optimize Research Funding
In the current fiscal environment, in which many excellent research applications are not funded and talented investigators struggle to maintain their laboratories, NIH seeks to create a stronger foundation for future researchers by optimizing its funding policies. Read the full article.
- More Positive Payline News
- Helpful Resources Available for Inclusion Management, Reproducibility, Peer Review
- NIH Clarifies Racial and Ethnic Categories and Definitions
- Summer Dates for Small Business Conferences
Act Sooner Than Later to Resolve a Bar to Award
Your overall impact/priority score might be the number on your summary statement that interests you most, but check for another important one: 44, as in a code 44. Read the full article.
- I am listed as key personnel on an R01, working on the project through a subaward. My institution considers me the PI of the subaward. Does this affect my new investigator status?
- When NIH reissues a funding opportunity announcement, is the pool of applicants limited to awardees who are currently funded?
New Funding Opportunities
- RFA-AI-15-025, Hepatitis C Cooperative Research Centers: Immunity to HCV Infection
- RFA-AI-15-019, Innovation for HIV Vaccine Discovery
- RFP-NIAID-DMID-NIHAI2015039, Microbiology and Infectious Diseases Biological Research Repository (MID-BRR)
- RFA-AI-15-020, NIH-PEPFAR Collaboration on Implementation Science for HIV: Towards an AIDS-Free Generation (R01)
- RFA-AI-15-021, NIH-PEPFAR Collaboration on Implementation Science for HIV: Towards an AIDS-Free Generation (R21)
- PAR-15-189, Lasker Clinical Research Scholars Program
- RFA-AI-15-022, Consortia for Innovative AIDS Research in Nonhuman Primates
See other announcements at NIAID Funding Opportunities List.
Send suggestions or comments to email@example.com.